Crescita Therapeutics Inc (CTX) — Capital Reinvestment Ratio
Latest as of December 2025:
1.74x
Crescita Therapeutics Inc (CTX) has a Capital Reinvestment Ratio of 1.74x as of December 2025, meaning it reinvests 2% of its operating cash flow (CA$416.00K) in capital expenditures (CA$724.00K). See how much free cash does Crescita Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.74x
Capex / Operating Cash Flow
Operating Cash Flow
CA$416.00K
CAD
Capital Expenditures
CA$724.00K
CAD
Data as of
Dec 2025
Most recent filing
Crescita Therapeutics Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Crescita Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Crescita Therapeutics Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Crescita Therapeutics Inc from 2019 to 2025. For live market cap and broader valuation context, see CTX company net worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CA$1.07 Million | CA$333.00K | ▼ -28.6% |
| 2024 | 0.43x | CA$2.73 Million | CA$1.19 Million | ▲ +578.8% |
| 2023 | 0.06x | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.01x | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.04x | CA$5.31 Million | CA$215.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow